Machine Learning

With a detailed M&A playbook, Standard Dental Labs aims to consolidate the dental lab industry. Can its disciplined strategy turn a micro-cap into a market leader?

Once an agricultural heartland, China's Anhui province is now a global hub for EVs and robotics. Discover the policies and projects driving its meteoric rise.

With Apple's durable new iPhone 17e on the market, Socket Mobile’s latest scanning solutions are turning the popular smartphone into a powerhouse for warehouses.

Blade Outboards' new Halo Connect app brings real-time data, GPS security, and over-the-air updates to its electric motors, aiming to redefine the standard.

Alpha Modus resolves its patent lawsuit against Brookshire Grocery, highlighting an aggressive IP strategy in the booming AI retail technology sector.

As cyber threats escalate, TSplus Advanced Security v7.5 delivers a multi-layered defense for Windows servers, targeting ransomware before it strikes.

Brazilian aerospace giant Embraer shatters financial records and builds its largest-ever order book, signaling a robust recovery in global aviation.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.

MEXC Foundation and UNCB launch MEXCampus at UNSW, a new program teaching crypto trading to students, sparking a debate on opportunity versus risk.

Australia's TGA approves Claritas iPET™, an AI tool that promises faster, lower-dose PET scans, boosting hospital efficiency and patient safety.

With a massive ₹16,000 crore raised, Navi Finserv gathers industry leaders to showcase its tech-first model, aiming to reshape India's credit market.

A new report reveals Gen Z women are rejecting old labels and hustle culture, prioritizing mental health, authentic living, and tech on their own terms.

Thinkific reports strong 2025 revenue and a return to profitability, betting its future on enterprise clients and its new 'Thinker' AI platform.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

The data center giant raises major capital to double its capacity, targeting the explosive growth in AI and cloud computing. Here's what it means.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

As Hyperfine preps its 2025 results, investors and clinicians watch to see if its portable Swoop MRI can translate clinical promise into financial success.

With a strong cash position, ArriVent pushes its lead lung cancer drug toward a mid-2026 data readout while building a new pipeline in ADCs.